<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2023-3-128-138</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-2041</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL STUDIES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group></article-categories><title-group><article-title>Molecular mechanisms of synergistic analgesic and neuroprotective action of B group vitamins according to the results of proteomic analysis</article-title><trans-title-group xml:lang="ru"><trans-title>Молекулярные механизмы синергического противоболевого и нейропротективного действия витаминов группы В по результатам протеомного анализа</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Алексеевна Громова</p><p>211933, Москва, ул. Вавилова, 4,</p></bio><bio xml:lang="en"><p>Olga Alekseevna Gromova</p><p>44, Vavilovа St., Build. 2, Moscow 119333</p></bio><email xlink:type="simple">unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2659-7998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торшин</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Torshin</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>211933, Москва, ул. Вавилова, 4,</p></bio><bio xml:lang="en"><p>44, Vavilovа St., Build. 2, Moscow 119333</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральный исследовательский центр «Информатика и управление» Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Center “Computer Science and Management”, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>04</day><month>07</month><year>2023</year></pub-date><volume>15</volume><issue>3</issue><fpage>128</fpage><lpage>138</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Gromova O.A., Torshin I.Y., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Громова О.А., Торшин И.Ю.</copyright-holder><copyright-holder xml:lang="en">Gromova O.A., Torshin I.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/2041">https://nnp.ima-press.net/nnp/article/view/2041</self-uri><abstract><p>We present the results of a systemic biological analysis of human proteome proteins, biological functions of which are somehow related to the metabolism of B group vitamins and the molecular implementation of nociceptive processes. Among 983 proteins involved in the homeostasis of B vitamins, 21 proteins were involved in the molecular mechanisms of nociception, 91 proteins were involved in the regulation of inflammation processes, and 17 proteins were involved in the neuroprotective and neurotrophic effects of B vitamins. All these groups of proteins are important for the treatment of neuropathic pain associated with the degeneration of nervous tissue.</p></abstract><trans-abstract xml:lang="ru"><p>Представлены результаты системно-биологического анализа белков протеома человека, биологические функции которых так или иначе связаны с метаболизмом витаминов группы В и с молекулярной реализацией ноцицептивных процессов. Среди 983 белков, вовлеченных в гомеостаз витаминов группы В, в молекулярных механизмах ноцицепции участвовал 21 белок, в регуляции процессов воспаления – 91 белок, в осуществлении нейропротекторных и нейротрофических эффектов витаминов группы В – 17 белков. Все эти группы белков важны для лечения невропатической боли, связанной с дегенерацией нервной ткани.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>витамины группы В</kwd><kwd>ноцицепция</kwd><kwd>аналгезия</kwd><kwd>биоинформатика</kwd><kwd>Комплигам В Комплекс</kwd></kwd-group><kwd-group xml:lang="en"><kwd>B group vitamins</kwd><kwd>nociception</kwd><kwd>analgesia</kwd><kwd>bioinformatics</kwd><kwd>Compligam B Complex. Contact:</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при поддержке гранта Российского научного фонда (№ 20-12-00175-п), Ивановский государственный химико-технологический университет</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Aleshin VA, Mkrtchyan GV, Bunik VI. Mechanisms of Non-coenzyme Action of Thiamine: Protein Targets and Medical Significance. Biochemistry (Mosc). 2019 Aug;84(8):829-50. doi: 10.1134/S0006297919080017</mixed-citation><mixed-citation xml:lang="en">Aleshin VA, Mkrtchyan GV, Bunik VI. Mechanisms of Non-coenzyme Action of Thiamine: Protein Targets and Medical Significance. Biochemistry (Mosc). 2019 Aug;84(8):829-50. doi: 10.1134/S0006297919080017</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин ИЮ, Громова ОА. О неврологических функциях и синергизме витаминов B1, B6 иB12. Российский журнал боли. 2022;20(1):56-64. doi: 10.17116/pain20222001156</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Gromova OA. Neurological functions and synergism of vitamins B1, B6 and B12. Rossiyskiy zhurnal boli = Russian Journal of Pain. 2022;20(1):56-64. doi: 10.17116/pain20222001156 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu (ed. Gromova OA). Sensing the change from molecular genetics to personalized medicine. NY, USA: Nova Biomedical Books; 2009. In “Bioinformatics in the PostGenomic Era” series. ISBN 1-60692-217-0</mixed-citation><mixed-citation xml:lang="en">Torshin IYu (ed. Gromova OA). Sensing the change from molecular genetics to personalized medicine. NY, USA: Nova Biomedical Books; 2009. In “Bioinformatics in the PostGenomic Era” series. ISBN 1-60692-217-0</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Громова ОА, Торшин ИЮ, Гусев ЕИ. Синергидные нейропротекторные эффекты тиамина, пиридоксина и цианокобаламина в рамках протеома человека. Фармакокинетика и фармакодинамика. 2017;(1):40-51.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Gusev EI. Synergistic neuroprotective effects of thiamine, pyridoxine and cyanocobalamin on the level of human proteome. Farmakokinetika i farmakodinamika = Pharmacokinetics and Pharmacodynamics. 2017;(1):40-51 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Громова ОА, Торшин ИЮ, Стаховская ЛВ, Федотова ЛЭ. Хемореактомный анализ молекул тиамина дисульфида, тиамина гидрохлорида и бенфотиамина. Неврология, нейропсихиатрия, психосоматика. 2017;9(2):50-7. doi: 10.14412/2074-27112017-2-50-57</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Stakhovskaya LV, Fedotova LE. Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, neuropsychiatry, psychosomatics. 2017;9(2):50-7. doi: 10.14412/2074-2711-2017-2-50-57 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor JM, Allen AM, Graham A. Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype. Clin Sci (Lond). 2014 Nov;127(10):603-13. doi: 10.1042/CS20140047</mixed-citation><mixed-citation xml:lang="en">Taylor JM, Allen AM, Graham A. Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype. Clin Sci (Lond). 2014 Nov;127(10):603-13. doi: 10.1042/CS20140047</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J, Huang J, Zhang Z, et al. Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain. Neural Plast. 2022 Aug 29;2022:8057854. doi: 10.1155/2022/8057854</mixed-citation><mixed-citation xml:lang="en">Liu J, Huang J, Zhang Z, et al. Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain. Neural Plast. 2022 Aug 29;2022:8057854. doi: 10.1155/2022/8057854</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bettendorff L, Goessens G, Sluse F, et al. Thiamine deficiency in cultured neuroblastoma cells: effect on mitochondrial function and peripheral benzodiazepine receptors. J Neurochem. 1995 May;64(5):2013-21. doi: 10.1046/j.1471-4159.1995.64052013.x</mixed-citation><mixed-citation xml:lang="en">Bettendorff L, Goessens G, Sluse F, et al. Thiamine deficiency in cultured neuroblastoma cells: effect on mitochondrial function and peripheral benzodiazepine receptors. J Neurochem. 1995 May;64(5):2013-21. doi: 10.1046/j.1471-4159.1995.64052013.x</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">El Hajj Chehadeh S, Dreumont N, Willekens J, et al. Early methyl donor deficiency alters cAMP signaling pathway and neurosteroidogenesis in the cerebellum of female rat pups. Am J Physiol Endocrinol Metab. 2014 Dec 1;307(11):E1009-19. doi: 10.1152/ajpendo.00364.2014</mixed-citation><mixed-citation xml:lang="en">El Hajj Chehadeh S, Dreumont N, Willekens J, et al. Early methyl donor deficiency alters cAMP signaling pathway and neurosteroidogenesis in the cerebellum of female rat pups. Am J Physiol Endocrinol Metab. 2014 Dec 1;307(11):E1009-19. doi: 10.1152/ajpendo.00364.2014</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Громова ОА, Торшин ИЮ, Кобалава ЖД, Сорокина МА. О фундаментальных и клинических аспектах синергидного действия магния и рибофлавина в терапевтической практике. Терапия. 2018;19(1):119-31.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Kobalava ZhD, Sorokina MA. About fundamental and clinical aspects of magnesium and ribolavine synergic action in therapeutic practice. Terapiya. 2018;19(1):119-31 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gorman KM, Meyer E, Grozeva D, et al. Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia. Am J Hum Genet. 2019 May 2;104(5):948-56. doi: 10.1016/j.ajhg.2019.03.005</mixed-citation><mixed-citation xml:lang="en">Gorman KM, Meyer E, Grozeva D, et al. Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia. Am J Hum Genet. 2019 May 2;104(5):948-56. doi: 10.1016/j.ajhg.2019.03.005</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chen K, Wang T, Li Y, et al. Rhodojaponin VI indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain. Acta Pharm Sin B. 2023 Mar;13(3):1326-36. doi: 10.1016/j.apsb.2023.01.021</mixed-citation><mixed-citation xml:lang="en">Chen K, Wang T, Li Y, et al. Rhodojaponin VI indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain. Acta Pharm Sin B. 2023 Mar;13(3):1326-36. doi: 10.1016/j.apsb.2023.01.021</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Huang SK, Lu CW, Lin TY, Wang SJ. Neuroprotective Role of the B Vitamins in the Modulation of the Central Glutamatergic Neurotransmission. CNS Neurol Disord Drug Targets. 2022;21(4):292-301. doi: 10.2174/1871527320666210902165739</mixed-citation><mixed-citation xml:lang="en">Huang SK, Lu CW, Lin TY, Wang SJ. Neuroprotective Role of the B Vitamins in the Modulation of the Central Glutamatergic Neurotransmission. CNS Neurol Disord Drug Targets. 2022;21(4):292-301. doi: 10.2174/1871527320666210902165739</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Громова ОА, Торшин ИЮ. Систематический анализ экспериментальной и клинической фармакологии никотинамида и перспективы лечения атеросклероза. Экспериментальная и клиническая гастроэнтерология. 2022;(10):111-25. doi: 10.31146/1682-8658-ecg-206-10-111-125</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu. Systematic analysis of the experimental and clinical pharmacology of nicotinamide and prospects for the treatment of atherosclerosis. Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2022;(10):111-25. doi: 10.31146/1682-8658-ecg-206-10-111-125 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kotaka M, Gover S, Vandeputte-Rutten L, et al. Structural studies of glucose-6-phosphate and NADP+ binding to human glucose-6phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr. 2005 May;61(Pt 5):495-504. doi: 10.1107/S0907444905002350</mixed-citation><mixed-citation xml:lang="en">Kotaka M, Gover S, Vandeputte-Rutten L, et al. Structural studies of glucose-6-phosphate and NADP+ binding to human glucose-6phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr. 2005 May;61(Pt 5):495-504. doi: 10.1107/S0907444905002350</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sun Q, Zhang BY, Zhang PA, et al. Downregulation of glucose-6-phosphate dehydrogenase contributes to diabetic neuropathic pain through upregulation of toll-like receptor 4 in rats. Mol Pain. 2019 JanDec;15:1744806919838659. doi: 10.1177/1744806919838659</mixed-citation><mixed-citation xml:lang="en">Sun Q, Zhang BY, Zhang PA, et al. Downregulation of glucose-6-phosphate dehydrogenase contributes to diabetic neuropathic pain through upregulation of toll-like receptor 4 in rats. Mol Pain. 2019 JanDec;15:1744806919838659. doi: 10.1177/1744806919838659</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Громова ОА, Рудаков КВ, Торшин ИЮ. Систематический анализ эффектов холина на нервную систему на основе биохимических маршрутов. Анализ независимой литературы по молекулярной фармакологии и клиническим исследованиям. Трудный пациент. 2009;7(4-5):13-8.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Rudakov KV, Torshin IYu. Systematic analysis of the effects of choline on the nervous system based on biochemical pathways. Analysis of independent literature on molecular pharmacology and clinical research. Trudnyy patsient. 2009;7(4-5):13-8 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tsuda M, Tozaki-Saitoh H, Inoue K. Platelet-activating factor and pain. Biol Pharm Bull. 2011;34(8):1159-62. doi: 10.1248/bpb.34.1159</mixed-citation><mixed-citation xml:lang="en">Tsuda M, Tozaki-Saitoh H, Inoue K. Platelet-activating factor and pain. Biol Pharm Bull. 2011;34(8):1159-62. doi: 10.1248/bpb.34.1159</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Motoyama N, Morita K, Kitayama T, et al. Pain-releasing action of platelet-activating factor (PAF) antagonists in neuropathic pain animal models and the mechanisms of action. Eur J Pain. 2013 Sep;17(8):1156-67. doi: 10.1002/j.1532-2149.2013.00289.x</mixed-citation><mixed-citation xml:lang="en">Motoyama N, Morita K, Kitayama T, et al. Pain-releasing action of platelet-activating factor (PAF) antagonists in neuropathic pain animal models and the mechanisms of action. Eur J Pain. 2013 Sep;17(8):1156-67. doi: 10.1002/j.1532-2149.2013.00289.x</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Tager AM, LaCamera P, Shea BS, et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med. 2008 Jan;14(1):45-54. doi: 10.1038/nm1685</mixed-citation><mixed-citation xml:lang="en">Tager AM, LaCamera P, Shea BS, et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med. 2008 Jan;14(1):45-54. doi: 10.1038/nm1685</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Carvalho OP, Thornton GK, Hertecant J, et al. A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J Med Genet. 2011 Feb;48(2):131-5. doi: 10.1136/jmg.2010.081455</mixed-citation><mixed-citation xml:lang="en">Carvalho OP, Thornton GK, Hertecant J, et al. A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J Med Genet. 2011 Feb;48(2):131-5. doi: 10.1136/jmg.2010.081455</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Einarsdottir E, Carlsson A, Minde J, et al. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet. 2004 Apr 15;13(8):799-805. doi: 10.1093/hmg/ddh096</mixed-citation><mixed-citation xml:lang="en">Einarsdottir E, Carlsson A, Minde J, et al. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet. 2004 Apr 15;13(8):799-805. doi: 10.1093/hmg/ddh096</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Berry A, Aloe L, Rossi S, et al. Conjunctivally administered NGF antibody reduces pain sensitivity and anxiety-like behavioral responses in aged female mice. Behav Brain Res. 2010 Jul 11;210(2):284-7. doi: 10.1016/j.bbr.2010.02.037. Epub 2010 Feb 25.</mixed-citation><mixed-citation xml:lang="en">Berry A, Aloe L, Rossi S, et al. Conjunctivally administered NGF antibody reduces pain sensitivity and anxiety-like behavioral responses in aged female mice. Behav Brain Res. 2010 Jul 11;210(2):284-7. doi: 10.1016/j.bbr.2010.02.037. Epub 2010 Feb 25.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Громова ОА, Торшин ИЮ, Лиманова ОА, Никонов АА. Патофизиология вегетативно-сосудистых пароксизмов (приливы) у женщин в период менопаузы и механизм действия бета-аланина. Новая клинико-фармакологическая концепция. Гинекология. 2010;12(2):29-36.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Limanova OA, Nikonov AA. Pathophysiology of vegetativevascular paroxysms (hot flashes) in women during menopause and the mechanism of action of beta-alanine. New clinical and pharmacological concept. Ginekologiya = Gynecology. 2010;12(2):29-36 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Shi L, Tu BP. Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr Opin Cell Biol. 2015 Apr;33:12531. doi: 10.1016/j.ceb.2015.02.003</mixed-citation><mixed-citation xml:lang="en">Shi L, Tu BP. Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr Opin Cell Biol. 2015 Apr;33:12531. doi: 10.1016/j.ceb.2015.02.003</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Violante S, Ijlst L, van Lenthe H, et al. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling. Biochim Biophys Acta. 2010 Sep;1802(9):728-32. doi: 10.1016/j.bbadis.2010.06.002</mixed-citation><mixed-citation xml:lang="en">Violante S, Ijlst L, van Lenthe H, et al. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling. Biochim Biophys Acta. 2010 Sep;1802(9):728-32. doi: 10.1016/j.bbadis.2010.06.002</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Arelin M, Zierz S, Ceglarek U, et al. Recurrent Myalgia since Early InfancyMisleading Clinical Course in a Child with Carnitine Palmitoyltransferase-II Deficiency. Neuropediatrics. 2020 Feb;51(1):536. doi: 10.1055/s-0039-1694977</mixed-citation><mixed-citation xml:lang="en">Arelin M, Zierz S, Ceglarek U, et al. Recurrent Myalgia since Early InfancyMisleading Clinical Course in a Child with Carnitine Palmitoyltransferase-II Deficiency. Neuropediatrics. 2020 Feb;51(1):536. doi: 10.1055/s-0039-1694977</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Taggart RT, Smail D, Apolito C, Vladutiu GD. Novel mutations associated with carnitine palmitoyltransferase II deficiency. Hum Mutat. 1999;13(3):210-20. doi: 10.1002/(SICI)10981004(1999)13:3&lt;210::AID-HUMU5&gt;3.0.CO;2-0</mixed-citation><mixed-citation xml:lang="en">Taggart RT, Smail D, Apolito C, Vladutiu GD. Novel mutations associated with carnitine palmitoyltransferase II deficiency. Hum Mutat. 1999;13(3):210-20. doi: 10.1002/(SICI)10981004(1999)13:3&lt;210::AID-HUMU5&gt;3.0.CO;2-0</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Dawkins JL, Hulme DJ, Brahmbhatt SB, et al. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet. 2001 Mar;27(3):309-12. doi: 10.1038/85879</mixed-citation><mixed-citation xml:lang="en">Dawkins JL, Hulme DJ, Brahmbhatt SB, et al. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet. 2001 Mar;27(3):309-12. doi: 10.1038/85879</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Hanna MC, Turner AJ, Kirkness EF. Human pyridoxal kinase. cDNA cloning, expression, and modulation by ligands of the benzodiazepine receptor. J Biol Chem. 1997 Apr 18;272(16):1075660. doi: 10.1074/jbc.272.16.10756</mixed-citation><mixed-citation xml:lang="en">Hanna MC, Turner AJ, Kirkness EF. Human pyridoxal kinase. cDNA cloning, expression, and modulation by ligands of the benzodiazepine receptor. J Biol Chem. 1997 Apr 18;272(16):1075660. doi: 10.1074/jbc.272.16.10756</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Chelban V, Wilson MP, Warman Chardon J, et al. PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. Ann Neurol. 2019 Aug;86(2):225-40. doi: 10.1002/ana.25524</mixed-citation><mixed-citation xml:lang="en">Chelban V, Wilson MP, Warman Chardon J, et al. PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. Ann Neurol. 2019 Aug;86(2):225-40. doi: 10.1002/ana.25524</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Han G, Gupta SD, Gable K, et al. Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc Natl Acad Sci U S A. 2009 May 19;106(20):8186-91. doi: 10.1073/pnas.0811269106</mixed-citation><mixed-citation xml:lang="en">Han G, Gupta SD, Gable K, et al. Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc Natl Acad Sci U S A. 2009 May 19;106(20):8186-91. doi: 10.1073/pnas.0811269106</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Mühle C, Reichel M, Gulbins E, Kornhuber J. Sphingolipids in psychiatric disorders and pain syndromes. Handb Exp Pharmacol. 2013;(216):431-56. doi: 10.1007/978-3-7091-1511-4_22</mixed-citation><mixed-citation xml:lang="en">Mühle C, Reichel M, Gulbins E, Kornhuber J. Sphingolipids in psychiatric disorders and pain syndromes. Handb Exp Pharmacol. 2013;(216):431-56. doi: 10.1007/978-3-7091-1511-4_22</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Waldrop GL, Holden HM, St Maurice M. The enzymes of biotin dependent CO2 metabolism: what structures reveal about their reaction mechanisms. Protein Sci. 2012 Nov;21(11):1597-619. doi: 10.1002/pro.2156</mixed-citation><mixed-citation xml:lang="en">Waldrop GL, Holden HM, St Maurice M. The enzymes of biotin dependent CO2 metabolism: what structures reveal about their reaction mechanisms. Protein Sci. 2012 Nov;21(11):1597-619. doi: 10.1002/pro.2156</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Zempleni J, Hassan YI, Wijeratne SS. Biotin and biotinidase deficiency. Expert Rev Endocrinol Metab. 2008 Nov 1;3(6):715-24. doi: 10.1586/17446651.3.6.715</mixed-citation><mixed-citation xml:lang="en">Zempleni J, Hassan YI, Wijeratne SS. Biotin and biotinidase deficiency. Expert Rev Endocrinol Metab. 2008 Nov 1;3(6):715-24. doi: 10.1586/17446651.3.6.715</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Abed AR, Abed A, Banafshe HR, et al. Effect of biotin supplementation on neuropathic pain induced by chronic constriction of the sciatic nerve in the rat. Res Pharm Sci. 2021 May 12;16(3):250-9. doi: 10.4103/1735-5362.314823</mixed-citation><mixed-citation xml:lang="en">Abed AR, Abed A, Banafshe HR, et al. Effect of biotin supplementation on neuropathic pain induced by chronic constriction of the sciatic nerve in the rat. Res Pharm Sci. 2021 May 12;16(3):250-9. doi: 10.4103/1735-5362.314823</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Oguma S, Ando I, Hirose T, et al. Biotin ameliorates muscle cramps of hemodialysis patients: a prospective trial. Tohoku J Exp Med. 2012 Jul;227(3):217-23. doi: 10.1620/tjem.227.217</mixed-citation><mixed-citation xml:lang="en">Oguma S, Ando I, Hirose T, et al. Biotin ameliorates muscle cramps of hemodialysis patients: a prospective trial. Tohoku J Exp Med. 2012 Jul;227(3):217-23. doi: 10.1620/tjem.227.217</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Chu CH, Cheng D. Expression, purification, characterization of human 3methylcrotonyl-CoA carboxylase (MCCC). Protein Expr Purif. 2007 Jun;53(2):421-7. doi: 10.1016/j.pep.2007.01.012</mixed-citation><mixed-citation xml:lang="en">Chu CH, Cheng D. Expression, purification, characterization of human 3methylcrotonyl-CoA carboxylase (MCCC). Protein Expr Purif. 2007 Jun;53(2):421-7. doi: 10.1016/j.pep.2007.01.012</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Boneh A, Baumgartner M, Hayman M, Peters H. Methylcrotonyl-CoA carboxylase (MCC) deficiency associated with severe muscle pain and physical disability in an adult. J Inherit Metab Dis. 2005;28(6):1139-40. doi: 10.1007/s10545-005-0163-1</mixed-citation><mixed-citation xml:lang="en">Boneh A, Baumgartner M, Hayman M, Peters H. Methylcrotonyl-CoA carboxylase (MCC) deficiency associated with severe muscle pain and physical disability in an adult. J Inherit Metab Dis. 2005;28(6):1139-40. doi: 10.1007/s10545-005-0163-1</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Лиманова ОА, Громова ОА, Торшин ИЮ и др. Систематический анализ молекулярно-физиологических эффектов миоинозитола: данные молекулярной биологии, экспериментальной и клинической медицины. Эффективная фармакотерапия. Акушерство и гинекология. 2013;28 (3):32-41.</mixed-citation><mixed-citation xml:lang="en">Limanova OA, Gromova OA, Torshin IYu, et al. Systematic analysis of the molecular physiological effects of myo-inositol: data from molecular biology, experimental and clinical medicine. Effektivnaya farmakoterapiya. Akusherstvo i ginekologiya = Effective Pharmacotherapy. Obstetrics and Gynecology. 2013;28(3):32-41 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Калачева АГ, Торшин ИЮ, Стельмашук ЕВ и др. Нейропротекторное действие миоинозитола на клеточной модели глутаматного стресса как основа для профилактики нарушений внутриутробного развития головного мозга. Фармакокинетика и фармакодинамика. 2018;(3):9-20. doi: 10.24411/2587-7836-2018-10018</mixed-citation><mixed-citation xml:lang="en">Kalacheva AG, Torshin IYu, Stelmashuk EV, et al. Neuroprotective effect of myoinositol on the cellular model of glutamate stress as a basis for the prevention of disorders of intrauterine development of the brain. Farmakokinetika i farmakodinamika = Pharmacokinetics and Pharmacodynamics. 2018;(3):9-20 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Larner J. D-chiro-inositol – its functional role in insulin action and its deficit in insulin resistance. Int J Exp Diabetes Res. 2002;3(1):47-60. doi: 10.1080/15604280212528</mixed-citation><mixed-citation xml:lang="en">Larner J. D-chiro-inositol – its functional role in insulin action and its deficit in insulin resistance. Int J Exp Diabetes Res. 2002;3(1):47-60. doi: 10.1080/15604280212528</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Rapiejko PJ, Northup JK, Evans T, et al. G-proteins of fat-cells. Role in hormonal regulation of intracellular inositol 1,4,5-trisphosphate. Biochem J. 1986 Nov 15;240(1):35-40. doi: 10.1042/bj2400035</mixed-citation><mixed-citation xml:lang="en">Rapiejko PJ, Northup JK, Evans T, et al. G-proteins of fat-cells. Role in hormonal regulation of intracellular inositol 1,4,5-trisphosphate. Biochem J. 1986 Nov 15;240(1):35-40. doi: 10.1042/bj2400035</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Ivison SM, Graham NR, Bernales CQ, et al. Protein kinase D interaction with TLR5 is required for inflammatory signaling in response to bacterial flagellin. J Immunol. 2007 May 1;178(9):5735-43. doi: 10.4049/jimmunol.178.9.5735</mixed-citation><mixed-citation xml:lang="en">Ivison SM, Graham NR, Bernales CQ, et al. Protein kinase D interaction with TLR5 is required for inflammatory signaling in response to bacterial flagellin. J Immunol. 2007 May 1;178(9):5735-43. doi: 10.4049/jimmunol.178.9.5735</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu H, Yang Y, Zhang H, et al. Interaction between protein kinase D1 and transient receptor potential V1 in primary sensory neurons is involved in heat hypersensitivity. Pain. 2008 Jul 31;137(3):574-88. doi: 10.1016/j.pain.2007.10.025</mixed-citation><mixed-citation xml:lang="en">Zhu H, Yang Y, Zhang H, et al. Interaction between protein kinase D1 and transient receptor potential V1 in primary sensory neurons is involved in heat hypersensitivity. Pain. 2008 Jul 31;137(3):574-88. doi: 10.1016/j.pain.2007.10.025</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Xu JT, Tu HY, Xin WJ, et al. Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats. Exp Neurol. 2007 Aug;206(2):269-79. doi: 10.1016/j.expneurol.2007.05.029</mixed-citation><mixed-citation xml:lang="en">Xu JT, Tu HY, Xin WJ, et al. Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats. Exp Neurol. 2007 Aug;206(2):269-79. doi: 10.1016/j.expneurol.2007.05.029</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Jin J, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem. 1998 Jan 23;273(4):2030-4. doi: 10.1074/jbc.273.4.2030</mixed-citation><mixed-citation xml:lang="en">Jin J, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem. 1998 Jan 23;273(4):2030-4. doi: 10.1074/jbc.273.4.2030</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Zou Y, Yang R, Li L, et al. Purinergic signaling: a potential therapeutic target for depression and chronic pain. Purinergic Signal. 2023 Mar;19(1):163-72. doi: 10.1007/s11302-02109801-x</mixed-citation><mixed-citation xml:lang="en">Zou Y, Yang R, Li L, et al. Purinergic signaling: a potential therapeutic target for depression and chronic pain. Purinergic Signal. 2023 Mar;19(1):163-72. doi: 10.1007/s11302-02109801-x</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Jimenez E, Zafra F, Perez-Sen R, et al. P2Y purinergic regulation of the glycine neurotransmitter transporters. J Biol Chem. 2011 Mar 25;286(12):10712-24. doi: 10.1074/jbc.M110.167056</mixed-citation><mixed-citation xml:lang="en">Jimenez E, Zafra F, Perez-Sen R, et al. P2Y purinergic regulation of the glycine neurotransmitter transporters. J Biol Chem. 2011 Mar 25;286(12):10712-24. doi: 10.1074/jbc.M110.167056</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Torres R, Croll SD, Vercollone J, et al. Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses. Pain. 2007 Aug;130(3):267-78. doi: 10.1016/j.pain.2007.01.036</mixed-citation><mixed-citation xml:lang="en">Torres R, Croll SD, Vercollone J, et al. Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses. Pain. 2007 Aug;130(3):267-78. doi: 10.1016/j.pain.2007.01.036</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Greenberg JA, Bell SJ, Guan Y, Yu YH. Folic Acid supplementation and pregnancy: more than just neural tube defect prevention. Rev Obstet Gynecol. 2011 Summer;4(2):52-9.</mixed-citation><mixed-citation xml:lang="en">Greenberg JA, Bell SJ, Guan Y, Yu YH. Folic Acid supplementation and pregnancy: more than just neural tube defect prevention. Rev Obstet Gynecol. 2011 Summer;4(2):52-9.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang W, Tan XY, Li JM, et al. DNA Methylation: A Target in Neuropathic Pain. Front Med (Lausanne). 2022 Jul 7;9:879902. doi: 10.3389/fmed.2022.879902. eCollection 2022.</mixed-citation><mixed-citation xml:lang="en">Jiang W, Tan XY, Li JM, et al. DNA Methylation: A Target in Neuropathic Pain. Front Med (Lausanne). 2022 Jul 7;9:879902. doi: 10.3389/fmed.2022.879902. eCollection 2022.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang R, Huang M, Cao Z, et al. MeCP2 plays an analgesic role in pain transmission through regulating CREB / miR-132 pathway. Mol Pain. 2015 Apr 12;11:19. doi: 10.1186/s12990-015-0015-4</mixed-citation><mixed-citation xml:lang="en">Zhang R, Huang M, Cao Z, et al. MeCP2 plays an analgesic role in pain transmission through regulating CREB / miR-132 pathway. Mol Pain. 2015 Apr 12;11:19. doi: 10.1186/s12990-015-0015-4</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Wolthers KR, Lou X, Toogood HS, et al. Mechanism of coenzyme binding to human methionine synthase reductase revealed through the crystal structure of the FNR-like module and isothermal titration calorimetry. Biochemistry. 2007 Oct 23;46(42):11833-44. doi: 10.1021/bi701209p. Epub 2007 Sep 25.</mixed-citation><mixed-citation xml:lang="en">Wolthers KR, Lou X, Toogood HS, et al. Mechanism of coenzyme binding to human methionine synthase reductase revealed through the crystal structure of the FNR-like module and isothermal titration calorimetry. Biochemistry. 2007 Oct 23;46(42):11833-44. doi: 10.1021/bi701209p. Epub 2007 Sep 25.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Menon S, Lea RA, Roy B, et al. Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation. Pharmacogenet Genomics. 2012 Oct;22(10):7419. doi: 10.1097/FPC.0b013e3283576b6b</mixed-citation><mixed-citation xml:lang="en">Menon S, Lea RA, Roy B, et al. Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation. Pharmacogenet Genomics. 2012 Oct;22(10):7419. doi: 10.1097/FPC.0b013e3283576b6b</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Brown GM. The biosynthesis of folic acid. II. Inhibition by sulfonamides. J Biol Chem. 1962 Feb;237:536-40.</mixed-citation><mixed-citation xml:lang="en">Brown GM. The biosynthesis of folic acid. II. Inhibition by sulfonamides. J Biol Chem. 1962 Feb;237:536-40.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Maki T, Takeda K. Benzoic Acid and Derivatives. In: Ullmann’s Encyclopedia of Industrial Chemistry. Wiley-VCH. doi: 10.1002/14356007.a03_555. ISBN 3527306730</mixed-citation><mixed-citation xml:lang="en">Maki T, Takeda K. Benzoic Acid and Derivatives. In: Ullmann’s Encyclopedia of Industrial Chemistry. Wiley-VCH. doi: 10.1002/14356007.a03_555. ISBN 3527306730</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Takahashi N, Kuwaki T, Kiyonaka S, et al. TRPA1 underlies a sensing mechanism for O2. Nat Chem Biol. 2011 Aug 28;7(10):70111. doi: 10.1038/nchembio.640</mixed-citation><mixed-citation xml:lang="en">Takahashi N, Kuwaki T, Kiyonaka S, et al. TRPA1 underlies a sensing mechanism for O2. Nat Chem Biol. 2011 Aug 28;7(10):70111. doi: 10.1038/nchembio.640</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Kremeyer B, Lopera F, Cox JJ, et al. A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron. 2010 Jun 10;66(5):671-80. doi: 10.1016/j.neuron.2010.04.030</mixed-citation><mixed-citation xml:lang="en">Kremeyer B, Lopera F, Cox JJ, et al. A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron. 2010 Jun 10;66(5):671-80. doi: 10.1016/j.neuron.2010.04.030</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Bang S, Yang TJ, Yoo S, et al. Inhibition of sensory neuronal TRPs contributes to anti-nociception by butamben. Neurosci Lett. 2012 Jan 11;506(2):297-302. doi: 10.1016/j.neulet.2011.11.026</mixed-citation><mixed-citation xml:lang="en">Bang S, Yang TJ, Yoo S, et al. Inhibition of sensory neuronal TRPs contributes to anti-nociception by butamben. Neurosci Lett. 2012 Jan 11;506(2):297-302. doi: 10.1016/j.neulet.2011.11.026</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Itoh Y, Hatano N, Hayashi H, et al. An environmental sensor, TRPV4 is a novel regulator of intracellular Ca2+ in human synoviocytes. Am J Physiol Cell Physiol. 2009 Nov;297(5):C1082-90. doi: 10.1152/ajpcell.00204.2009</mixed-citation><mixed-citation xml:lang="en">Itoh Y, Hatano N, Hayashi H, et al. An environmental sensor, TRPV4 is a novel regulator of intracellular Ca2+ in human synoviocytes. Am J Physiol Cell Physiol. 2009 Nov;297(5):C1082-90. doi: 10.1152/ajpcell.00204.2009</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Köttgen M, Buchholz B, Garcia-Gonzalez MA, et al. TRPP2 and TRPV4 form a polymodal sensory channel complex. J Cell Biol. 2008 Aug 11;182(3):437-47. doi: 10.1083/jcb.200805124</mixed-citation><mixed-citation xml:lang="en">Köttgen M, Buchholz B, Garcia-Gonzalez MA, et al. TRPP2 and TRPV4 form a polymodal sensory channel complex. J Cell Biol. 2008 Aug 11;182(3):437-47. doi: 10.1083/jcb.200805124</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Boehmerle W, Huehnchen P, Lee SLL, et al. TRPV4 inhibition prevents paclitaxel-induced neurotoxicity in preclinical models. Exp Neurol. 2018 Aug;306:64-75. doi: 10.1016/j.expneurol.2018.04.014</mixed-citation><mixed-citation xml:lang="en">Boehmerle W, Huehnchen P, Lee SLL, et al. TRPV4 inhibition prevents paclitaxel-induced neurotoxicity in preclinical models. Exp Neurol. 2018 Aug;306:64-75. doi: 10.1016/j.expneurol.2018.04.014</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Günes HN, Bekircan-Kurt CE, Tan E, Erdem-Özdamar S. The histopathological evaluation of small fiber neuropathy in patients with vitamin B12 deficiency. Acta Neurol Belg. 2018 Sep;118(3):405-10. doi: 10.1007/s13760017-0847-y</mixed-citation><mixed-citation xml:lang="en">Günes HN, Bekircan-Kurt CE, Tan E, Erdem-Özdamar S. The histopathological evaluation of small fiber neuropathy in patients with vitamin B12 deficiency. Acta Neurol Belg. 2018 Sep;118(3):405-10. doi: 10.1007/s13760017-0847-y</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Wu F, Xu K, Liu L, et al. Vitamin B(12) Enhances Nerve Repair and Improves Functional Recovery After Traumatic Brain Injury by Inhibiting ER Stress-Induced Neuron Injury. Front Pharmacol. 2019 Apr 24;10:406. doi: 10.3389/fphar.2019.00406</mixed-citation><mixed-citation xml:lang="en">Wu F, Xu K, Liu L, et al. Vitamin B(12) Enhances Nerve Repair and Improves Functional Recovery After Traumatic Brain Injury by Inhibiting ER Stress-Induced Neuron Injury. Front Pharmacol. 2019 Apr 24;10:406. doi: 10.3389/fphar.2019.00406</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J, Wang W, Zhong XX, et al. EXPRESS: Methylcobalamin ameliorates neuropathic pain induced by vincristine in rats: Effect on loss of peripheral nerve fibers and imbalance of cytokines in the spinal dorsal horn. Mol Pain. 2016 Jun 15;12:1744806916657089. doi: 10.1177/1744806916657089</mixed-citation><mixed-citation xml:lang="en">Xu J, Wang W, Zhong XX, et al. EXPRESS: Methylcobalamin ameliorates neuropathic pain induced by vincristine in rats: Effect on loss of peripheral nerve fibers and imbalance of cytokines in the spinal dorsal horn. Mol Pain. 2016 Jun 15;12:1744806916657089. doi: 10.1177/1744806916657089</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Громова ОА, Торшин ИЮ, Путилина МВ и др. О механизмах синергидного действия толперизона, мелоксикама и витаминов группы В в терапии периферических болевых синдромов. Медицинский совет. 2020;(8):5464. doi: 10.21518/2079-701X-2020-8-54-64</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Putilina MV, et al. On the mechanisms of the synergistic action of tolperisone, meloxicam and B vitamins in the treatment of peripheral pain syndromes. Meditsinskiy sovet = Medical Council. 2020;(8):54-64. doi: 10.21518/2079701X-2020-8-54-64 (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Gharibpoor F, Ghavidel-Parsa B, Sattari N, et al. Effect of vitamin B12 on the symptom severity and psychological profile of fibromyalgia patients; a prospective pre-post study. BMC Rheumatol. 2022 Sep 1;6(1):51. doi: 10.1186/s41927-022-00282-y</mixed-citation><mixed-citation xml:lang="en">Gharibpoor F, Ghavidel-Parsa B, Sattari N, et al. Effect of vitamin B12 on the symptom severity and psychological profile of fibromyalgia patients; a prospective pre-post study. BMC Rheumatol. 2022 Sep 1;6(1):51. doi: 10.1186/s41927-022-00282-y</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Karedath J, Batool S, Arshad A, et al. The Impact of Vitamin B12 Supplementation on Clinical Outcomes in Patients With Diabetic Neuropathy: A Meta-Analysis of Randomized Controlled Trials. Cureus. 2022 Nov 22;14(11):e31783. doi: 10.7759/cureus.31783</mixed-citation><mixed-citation xml:lang="en">Karedath J, Batool S, Arshad A, et al. The Impact of Vitamin B12 Supplementation on Clinical Outcomes in Patients With Diabetic Neuropathy: A Meta-Analysis of Randomized Controlled Trials. Cureus. 2022 Nov 22;14(11):e31783. doi: 10.7759/cureus.31783</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Didangelos T, Karlafti E, Kotzakioulafi E, et al. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, DoubleBlind, Placebo-Controlled Trial. Nutrients. 2021;13(2):395. doi: 10.3390/nu13020395</mixed-citation><mixed-citation xml:lang="en">Didangelos T, Karlafti E, Kotzakioulafi E, et al. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, DoubleBlind, Placebo-Controlled Trial. Nutrients. 2021;13(2):395. doi: 10.3390/nu13020395</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang A, Ackley BD, Yan D. Vitamin B12 Regulates Glial Migration and Synapse Formation through Isoform-Specific Control of PTP-3/LAR PRTP Expression. Cell Rep. 2020 Mar 24;30(12):3981-8.e3. doi: 10.1016/j.celrep.2020.02</mixed-citation><mixed-citation xml:lang="en">Zhang A, Ackley BD, Yan D. Vitamin B12 Regulates Glial Migration and Synapse Formation through Isoform-Specific Control of PTP-3/LAR PRTP Expression. Cell Rep. 2020 Mar 24;30(12):3981-8.e3. doi: 10.1016/j.celrep.2020.02</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
